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Abstract
Biologically mobile zinc and nitric oxide (NO) are two prominent examples of inorganic
compounds involved in numerous signaling pathways in living systems. In the past decade, a
synergy of regulation, signaling, and translocation of these two species has emerged in several
areas of human physiology, providing additional incentive for developing adequate detection
systems for Zn(II) ions and NO in biological specimens. Fluorescent probes for both of these
bioinorganic analytes provide excellent tools for their detection, with high spatial and temporal
resolution. We review the most widely used fluorescent sensors for biological zinc and nitric
oxide, together with promising new developments and unmet needs of contemporary Zn(II) and
NO biological imaging. The interplay between zinc and nitric oxide in the nervous, cardiovascular,
and immune systems is highlighted to illustrate the contributions of selective fluorescent probes to
the study of these two important bioinorganic analytes.
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1. INTRODUCTION
The interface between inorganic chemistry and biology is an exciting one. All living systems
employ inorganic ions and molecules for biological function. Metal cations, inorganic
anions, and small-molecule gases interact with biological macromolecules to drive a
multitude of structural and catalytic processes. Of much current interest are the dynamic
signaling roles of a variety of inorganic species, which drive physiological processes or,
when uncontrolled, trigger pathology. The present review focuses on mobile forms of the
divalent zinc cation and the gaseous nitric oxide radical as two prominent examples of
inorganic species that participate in biological signaling networks in a manner that is not
fully elucidated. The study of such signaling pathways can benefit greatly from novel
techniques that detect the time- and position-sensitive locale of biological analytes in live
cells and tissues. Small-molecule fluorescent probes, in particular, can respond in a direct
and selective manner to specific analytes. As such, they provide a valuable means to study
the generation, accumulation, and translocation of metal ions and other inorganic agents in
biology with both spatial and temporal resolution. As the fidelity of techniques to study
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important bioinorganic analytes increases, multifaceted signaling pathways have emerged in
biological regulation. In this context, selective fluorescent probes for zinc and nitric oxide
are revealing the dichotomous and often interconnected roles of these species in the nervous,
cardiovascular, and immune systems.
The divalent zinc cation, Zn(II), is ubiquitous in biology. Current database-mining
techniques estimate that approximately 10% of the human genome encodes for the zinc
proteome (1). Lewis acidic, redox inert in the biological medium, and adaptable to different
coordination geometries, this metal cation plays a structural and catalytic role in the
biochemistry of numerous metalloproteins (2). Moreover, zinc maintains a highly dynamic
role in cell biology owing to rapid ligand exchange reactions that characterize its
coordination chemistry (3). The intracellular pool of mobile zinc, variously known as free,
chelatable, or loosely bound zinc, is regulated by several proteins, including
metallothioneins (MTs) and zinc transporters of the ZnT and Zip families (4,5). This zinc
pool is capable of regulating other proteins and cellular processes through fluctuations of its
local concentration. The origins and consequences of such zinc signals are central to human
physiology and pathology (6,7).
In the central nervous system, some glutamatergic nerve terminals feature synaptic vesicles
containing millimolar quantities of zinc. Release of this vesicular zinc pool triggers
signaling pathways that impact physiological functions, including synaptic plasticity,
transmission, and long-term potentiation, as well as neuronal death processes connected to
ischemia, epilepsy, and Alzheimer’s disease (8–11). In pancreatic β-cells responsible for
controlling glucose levels in blood and central to the study of diabetes, zinc is involved in
multiple aspects of insulin metabolism, exemplified by the concomitant release of insulin
and zinc from secretory vesicles (12–14). In the prostate glandular epithelium, zinc
accumulation is essential for normal citrate production, and changes in mobile zinc
concentrations parallel the metabolic changes that lead to the development of prostate
malignancy (15–18).
In similar fashion to zinc, the biosynthesis and potentiation of nitric oxide (NO) is highly
regulated. Although recognized originally as an environmental pollutant arising from
incomplete combustion of nitrogen-containing molecules, NO is now understood to play
important and diverse roles in biology. After the initial discovery in 1987 that NO is the
endothelium-derived relaxing factor in the cardiovascular system (19,20), its multifaceted
roles in physiology and disease have grown to include prevalent functions in the
cardiovascular, immune, and nervous systems (21–27). Biosynthesized from L-arginine, NO
is ubiquitous in bacteria, plants, invertebrates, and mammals. Nitric oxide synthase (NOS), a
heme-containing enzyme, catalyzes the oxidation of L-arginine to L-citrulline with
concomitant consumption of one equivalent of O2 and subsequent release of NO. Two NOS
isoforms, neuronal NOS (nNOS, type I) and endothelial NOS (eNOS, type II), are calcium
dependent and expressed constitutively, whereas the third isoform, inducible NOS (iNOS,
type III), is calcium independent and expressed in cells associated with immune response
upon exposure to cytokines and/or endotoxins. The three NOS isoforms provide a large
range of biological NO concentrations, from nanomolar, for nNOS and eNOS, to
micromolar for iNOS. Although NOS was originally thought to be the sole source of
biological NO, recent work indicates that nitrite (NO2−) reduction is another source of its
biosynthesis (28,29). After initial generation, NO diffuses rapidly from its point of origin,
with an average lifetime from milliseconds to seconds, before reacting with, and often
altering the function of, other biomolecules.
Much of the chemistry of biological NO is associated with its potentiation because
misregulation leads to numerous pathologies. For example, hypertension, arteriolosclerosis,
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and impotence have all been associated with an underproduction of NO, whereas diabetes,
stroke, septic shock, multiple sclerosis, and cancer are connected with its overproduction
(30–38). Furthermore, high levels of nitric oxide can lead to the proliferation of downstream
reactive NO species (RNOSs), such as NO2− or peroxynitrite (ONOO−). RNOSs have been
implicated in carcinogenesis and several neurological disorders, including Alzheimer’s,
Parkinson’s, and Huntington’s diseases (39,40). As the biological understanding of NO
evolves, it is apparent that other NO-derived species, such as nitrosothiols, ONOO−,
nitrogen dioxide (NO2), dinitrogen trioxide (N2O3), nitroxyl (HNO), NO2−, and nitrate
(NO3−), may also have important biological functions (28,41,42).
In organ physiology, both zinc and NO dynamics are connected to multiple upstream and
downstream pathways through interactions with proteins, small-molecule modulators, and
other signaling agents. Recent information about the intersecting pathways of zinc and nitric
oxide provides exciting clues to the functional schemes of these inorganic species in
neurobiology, lung and heart physiology, and immunology. The complexity of such network
maps motivates the development of increasingly sophisticated approaches to sensing and
imaging these inorganic species in live cells and tissues. In the present review, we highlight
the current knowledge of the interplay between zinc and nitric oxide as it has emerged from
studies employing, among other tools, fluorescent detection systems to track these inorganic
species in biological settings. The most widely used probes for both analytes are covered,
and an emphasis is placed on promising new developments and unmet needs of
contemporary imaging studies of mobile Zn2+ and NO.
2. SENSING STRATEGIES
Fluorescence imaging of biological analytes offers an attractive platform for monitoring
biological processes in real time with high spatial resolution. Ideally, fluorescent probes
should maintain sufficient water solubility, membrane permeability, and low toxicity for
biocompatibility. Furthermore, low-energy excitation/emission and a large dynamic range
between the on and off states of the probe greatly enhance the efficacy of such indicators.
Depending on the nature of the experiment, sensor properties, such as reversibility, cell
trappability and selectivity, can impact experimental conditions and results. The
understanding of biological zinc and nitric oxide have benefited greatly from the
development of fluorescent probes. Readers interested in the full landscape of fluorescent
sensors available for mobile zinc (43–51) and nitric oxide (52–60) are referred to these
recent reviews. Below, we present a gallery of fluorescent zinc and nitric oxide indicators
used most widely for the study of the Zn/NO synergism and selected recent contributions
that address current challenges in zinc or NO imaging and may provide useful tools for
future studies.
2.1. Fluorescent Sensors for Mobile Zinc
Most zinc indicators employed in fluorescence microscopy experiments are intensity-based
sensors that respond to zinc coordination with an increase, or rarely a decrease, in
fluorescence emission intensity without a significant shift in emission wavelength. Although
such fluorescence turn on or turn off is readily imaged by current microscopy
instrumentation, zinc quantification is complicated by the dependency of intensity on dye
loading, cell thickness, photobleaching, and sensor diffusion to the extracellular medium,
and uneven cellular distribution of the indicator. Large changes in emission intensity upon
analyte binding, which reflect the dynamic range of the sensor, are preferred because they
provide better contrast in fluorescence micrographs. Low background and high turn-on
emission define the dynamic range.
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2.1.1. Turn-on fluorescent sensors for mobile zinc—Early fluorescent indicators
employed in experiments to investigate biologically mobile zinc were based on 8-substituted
quinoline platforms. For example, the formation of a fluorescent complex with 8-
hydroxyquinoline allowed for the detection of zinc in human plasma and urine (61) and, by
fluorescence microscopy, in the granules of cultured human leukocytes in the late 1960s
(62). Since then, the quinoline derivative 6-methoxy-8-p-toluenesulfonamidequinoline
(TSQ) (Figure 1) has been employed in many contexts for zinc bioimaging, including some
of the earliest observations of zinc in brain tissue by fluorescence microscopy (63). Its
analog Zinquin (Figure 1), available in both a carboxylic acid (Zinquin-A) and an ethyl ester
form (Zinquin-E), retains a similar photophysical profile but with improved cell staining and
retention properties (64). Zinc sensors of the 8-substituted quinoline family have detection
limits in the picomolar range and large (up to 100-fold) fluorescence turn-on responses. The
zinc-binding properties of such probes, however, are complicated by the tendency of these
bidentate ligands to form a mixture of 1:1 and 2:1 complexes (65). Furthermore, quinoline-
based indicators require excitation with UV light, which can result in both cellular
photodamage and autofluorescence, thus limiting the applicability of such probes in live-cell
experiments.
Fluorescein-based sensors constitute the largest family of indicators for biological zinc. The
success of these probes has relied on the stability, water solubility, brightness, and visible-
light excitation/emission of the fluorescein platform, as well as on the versatility of their
modular design based on a fluorophore-spacer-receptor scheme. The receptor units are built
around an electron-rich group, typically a secondary or tertiary amine, which quenches the
fluorophore by photoinduced-electron transfer (PET) in the absence of the metal ion. The
palette of available zinc sensors offers a selection of probes responsive in the desired
concentration range and selective for zinc over other competing ions.
In the design of probes of the large Zinpyr (ZP) family (48), receptors based on the di(2-
picolyl)amine (DPA) ligand were tethered to various fluorescein scaffolds. The first and
most widely used member of this series, ZP1 (Figure 1), offers good cell permeability and
optical brightness, zinc affinity in the low nanomolar range, and a fivefold increase of
fluorescence quantum yield upon zinc binding (Φfree 0.17, ΦZn 0.87) (66,67). Because
protonation of the basic receptor units can influence the PET quenching process, sensors of
the ZP family are pH sensitive. Potentiometric and fluorometric experiments on ZP1
correlated its pH-dependent fluorescence response to a pKa value of 7.0 for one of the
protonation equilibriums of the system (67). This event results in a relatively high
background fluorescence corresponding to partially protonated ZP1 at cellular pH. The
background fluorescence can be attenuated, at least in some applications, by
precomplexation of ZP1 with Mn(II). This paramagnetic ion quenches the fluorophore in the
zinc-free state and is promptly replaced by Zn(II) ions both in vitro and in live cells. This
displacement provides an improved turn-on response and better contrast in fluorescence
microscopy experiments (68).
Sensors of the ZP and the related families of sulfur-containing ZS sensors (69) and
quinoline-containing QZ sensors (70) span a wide range of zinc affinities and dynamic
ranges (48). In addition, the pyrazine-containing ZPP1 (Figure 1) can provide an in vitro
determination of zinc concentration in biological fluids through fluorometric titration
experiments (71). For example, in experiments using zinc as a cancer biomarker in a
transgenic mouse model of prostate adenocarcinoma, ZPP1 was used to quantitate zinc
concentrations in prostate cell lysates and mouse prostate extracts (18).
Functionalization of the bottom ring of the fluorescein scaffold defines the ZnAF family of
sensors carrying pyridine-rich receptors of varying denticity, chelate-ring size, and steric
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bulk (72). Constructs of this series cover a large spectrum of zinc affinities (73); however,
coordination of zinc does not fully restore the fluorescein emission, and the quantum
efficiencies of zinc complexes of the ZnAF probes generally remain below 0.4 in neutral
aqueous solution. One of the first members of this family, ZnAF-2 (Figure 1), exhibits
nanomolar affinity for zinc and low pH-independent background fluorescence in the absence
of zinc ions (72). ZnAF-2 is a membrane-impermeant indicator that can be employed to
monitor extracellular zinc release.
Several zinc sensors are based on the scaffold of established biocompatible calcium
indicators. In Newport Green DCF (Figure 1), for example, the calcium-binding BAPTA
[1,2-bis(o-aminophenoxy)ethane-N,N,N′,N′-tetracetic acid] unit of Calcium Green™-1 is
replaced with an aniline-fused DPA receptor (74). Newport Green DCF accommodates the
softer and less oxophilic zinc cation with micromolar affinity and high selectivity over
calcium and magnesium, although significant turn-on responses to nickel and cobalt have
been recorded (75). A close relative of the BAPTA-based calcium sensor Fluo-4, FluoZin-3
(Figure 1), features only three of the four N-acetate groups of the original probe, a
modification that produces greatly reduced affinity for calcium and nanomolar affinity for
zinc (76). FluoZin-3 responds to zinc binding with a 200-fold increase in fluorescence
emission and, in spite of its similarity to BAPTA-based receptors, is not perturbed by
millimolar calcium concentrations (77). The rhodamine-based analog of FluoZin-3,
RhodZin-3 (Figure 1), allows zinc detection at longer wavelengths with a 75-fold turn-on
response (40). Although RhodZin-3 is membrane impermeant, the acetoxymethyl ester
derivative is cell permeable and localizes in the mitochondria of eukaryotic cells, thus
allowing study of mitochondrial zinc pools (40).
2.1.2. Ratiometric fluorescent sensors for mobile zinc—A major focus of current
efforts in zinc sensor development is the design of ratiometric indicators (45,49). Such
probes respond to analyte binding with a shift of the corresponding excitation and/or
emission profiles. Because each ratio of emission and/or excitation intensity at two chosen
wavelengths corresponds to a specific analyte concentration, ratiometric sensors can be used
to determine zinc concentrations in dual excitation or dual emission experiments. Systems of
this type can supply valuable information on transient zinc levels in live cells or tissues,
provided that the receptors have sufficiently rapid and reversible binding kinetics. Although
several ratiometric, mostly UV-excitable probes for zinc in aqueous solution have been
reported in the past decade (45,46,76), none has found wide applicability in zinc bioimaging.
In two recent examples of visible-wavelength-excitable sensors that have been tested in live-
cell imaging experiments, coordination of zinc by the DPA unit is enhanced by additional
interactions with heteroatoms of the fluorophore scaffold. In ZnIC (Figure 2), DPA-bound
Zn(II) interacts with an iminocoumarin moiety, thereby influencing the internal charge
transfer process connected to the fluorescence emission (78). In the amide-DPA sensor
ZTRS (Figure 2), zinc coordination induces tautomerization of the amide moiety and causes
a red shift of the emission profile of the naphthalimide fluorophore directly connected to the
amide nitrogen atom (51).
Several promising ratiometric systems are based on zinc-induced modulation of
intramolecular Förster resonance energy transfer (FRET). For example, the fluorescein-
rhodamine construct 1 (Figure 2) relies on a zinc-induced ring opening of a rhodamine
spirolactam, thus restoring emission of the rhodamine fluorophore and resulting in FRET
between the xanthenone dyes. This modulation provides highly selective zinc detection over
a large concentration range (from 2.0 × 10−7 M to 2.0 × 10−5 M) by measuring the ratio of
the well-separated emission intensities of the two fluorophores (79).
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A versatile FRET-based sensor design features a pair of autofluorescent proteins separated
by a zinc-binding domain in which the conformational changes caused by zinc coordination
affect the FRET efficiency of the system and result in a ratiometric signal (50). Such
protein-based sensors can be genetically encoded by common molecular biology protocols
and can be fused to localizing sequences that anchor the biosensor to a targeted cellular site.
For instance, site-directed FRET-based biosensors were employed to detect zinc in the
mitochondria of hippocampal neurons (80) and in the insulin-containing granules of
pancreatic β-cells (81).
In an alternative approach to sensor localization, protein-labeling methodologies (82,83) can
be used to tether small-molecule indicators to protein tags genetically directed to a cellular
compartment of choice. In this fashion, the S-nitroso-N-acetylpenicillamine (SNAP) tag (84)
was employed to direct fluorescein-based sensor ZP1 to the Golgi apparatus and the
mitochondria of live HeLa cells (85). If combined with ratiometric detection, sensor
localization strategies will provide powerful tools for the dynamic description of zinc signals
with nanoscaled subcellular resolution. The lower limit of resolution for imaging by light
microscopy (~200 nm), which is increased by spatial averaging of the signal from freely
diffusing indicators, allows visualization of organelle “microdomains” in eukaryotic cells,
but it does not permit the study of smaller structures. Conversely, the genetic tethering of
sensors to specific subcellular compartments can illuminate “nanodomains,” such as
secretory granules and synaptic clefts, and allow one to distinguish between contiguous
compartments within the same structure. Only zinc’s presence at such a nanodomain will
trigger fluorescence.
2.2. Fluorescent Sensors for Nitric Oxide
The special physical properties of NO, such as its gaseous nature, limited water solubility
(~1.7 mM), complex oxidation chemistry, diverse biological concentrations, and radical
character, offer challenges in the design of selective probes for its detection. Classical
techniques, such as electron paramagnetic resonance spectroscopy, for identifying free
radicals lack the sensitivity and spatial resolution for use in live cells. Chemical traps for NO
that form stable nitroxide radicals, such as fluorescent nitric oxide chelotropic traps based on
the reaction of NO with o-quinodimethanes, have been developed but often suffer from
problems with biological selectivity, sensitivity, and toxicity (86–88). Although NO-
selective electrodes are valuable tools for tissue and whole blood measurements, they lack
the spatial resolution and noninvasiveness required for many sensing applications. By
contrast, optical methods for NO detection and quantification have produced increasingly
accurate tools for elucidating the numerous roles of biological nitric oxide.
2.2.1. Organic probes for nitric oxide—The Griess assay, which relies on the reaction
of NO2−, an oxidation product of NO, with sulfanilic acid and α-naphthalene under acidic
conditions to produce an azo dye quantifiable by absorption spectroscopy, was one of the
early methods for optical detection of NO (89,90). This method allows for quantification of
NO2− concentrations based on a calibration curve with a lower detection limit of
approximately 0.5 µM. Refined variants of the Griess assay using sulfanilamide and N-(1-
naphthyl)ethylenediamine produced a more sensitive and reproducible assay. Because the
Griess assay is a bulk measurement and measures NO indirectly, determination of
background NO2− cellular concentrations is important for reliable quantification.
By comparison to absorption-based measurements, fluorescent probes offer a class of
important tools for cell culture, tissue slice, and whole-animal studies resulting from their
sensitivity, optical resolution, generally available instrumentation, and ease of use. In the
development of small-molecule fluorescent probes for nitric oxide, two distinct strategies
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have emerged. The first, and more widely used, is based on entirely organic probes in which
an oxidation product of NO, such as N2O3, reacts with a functional group to modulate the
fluorescence (91). Such probes often result in bright (50–150-fold) emission enhancement in
the presence of nitric oxide under aerobic conditions. A second strategy for devising
fluorescence probes for nitric oxide is the use of transition metals to mediate reactivity of an
emissive dye with NO. Such probes benefit from faster reaction times with NO owing to
metal-mediated reactivity, but these probes can be less bright than purely organic probes
when comparing their on and off states.
Numerous fluorescent probes for nitric oxide utilize the electron-rich 1,2-diaminobenzene
moiety, which reacts with oxidization products of NO to form an electron-poor triazole
(Figure 3). Introduction of a diamine unit to a fluorophore generally results in PET from the
amine lone pairs to the excited fluorophore to quench the emission. Conversion of the
diamine to an aryltriazole lowers the energy of the nitrogen lone pairs, thereby abolishing
the PET pathway and restoring fluorophore emission. An early example of this reactivity for
NO detection used 2,3-diaminonaphthalene (DAN) (Figure 3), which is converted to the
fluorescent 2,3-naphthotriazole upon exposure to NO in an aerobic environment (92,93).
The cellular viability of DAN, however, is reduced by the required high-energy UV
excitation and emission. This assay has been optimized as a biological NO2− assay, with a
detection limit of approximately 10 nM, thereby providing increased sensitivity over the
Griess assay (92).
The most common NO probes rely on the same aryldiamine-to-triazole conversion manifold
but make use of biologically compatible fluorescein dyes. Diaminofluoresceins (DAFs)
(Figure 3), incorporating the o-diamine moiety on the lower fluorescein ring, are selective
for NO over NO3−, ONOO−, H2O2, and O2− under aerobic conditions and maintain a 5-nM
NO detection limit (94–96). Such probes benefit from visible excitation wavelengths, thus
limiting interference from cellular autofluorescence and minimizing tissue damage during
imaging. As in the Griess assay, DAF-based probes do not measure NO directly but rather
monitor its oxidation products, such as N2O3. Their applicability is therefore limited in
hypoxic cellular environments. Measurement of NO can be perturbed by the presence of
dehydroascorbic acid or ascorbic acid, which form products with emission profiles similar to
that of NO-derived triazoles, or by intracellular reductants, such as homocysteine and
reduced glutathione (76,97). Similarly, divalent cations increase the fluorescence of DAF
probes prior to triazole formation, potentially complicating an observed emission (98).
Although the parent DAF probes are cell membrane impermeable, esterification of the
phenolate oxygen atoms imparts cell permeability (DAF-2 DA) (Figure 3). Upon cellular
uptake, hydrolysis by intracellular esterases releases the active DAF-2 probe. The
fluorescence of the triazole product, however, is pH dependent owing to protonation of the
secondary amine of the triazole. This limitation can be attenuated by monomethylation of
one of the diamine nitrogens and partial fluorination of the fluorescein platform (DAF-FM)
(Figure 3) both to change the basicity of the triazole product and to increase its
photostability (99). Much like the parent DAF probes, esterification of the phenolic oxygen
atoms (DAF-FM DA) (Figure 3) results in a cell-permeable and trappable probe.
Other fluorophores have also been functionalized with diaminobenzene moieties to effect
NO sensing. Diaminorhodamines (DARs) (Figure 3) (100) exhibit improved excitation
profiles, photostability, and pH tolerance when compared to DAF analogs. Optimization of
cell membrane permeability, intracellular hydrolysis rates, and intracellular localization led
to the development of DAR-M, incorporating an acetoxymethyl ester to impart cell
permeability and trappability, as well as nitrogen alkylation to lower the pH sensitivity of
the triazole fluorescence.
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Red fluorescent NO probes have also been developed based on the 1,2-
diaminoanthraquinone (DAQ) (Figure 3) platform. DAQ itself is nonfluorescent, but
conversion to the triazole 1H-antra[1,2d]-[1,2,3]-triazole-6,11-dione (ATD) results in bright
fluorescence (101,102). DAQ effectively responds to both intra- and extracellular NO, and
unlike the DAF triazole product, ATD is insoluble in water and precipitates upon formation,
thus eliminating passive diffusion from the point of generation. This property allows for its
fluorescence to be investigated even in fixed tissues. For other desired properties, such as
pH insensitivity or longer-wavelength emission, researchers have utilized the o-diamine/NO
reactivity manifold. Probes based on the BODIPY framework, such as DAMBO-PH or
DAMBOO (Figure 3), were developed that have higher NO sensitivity than DAF analogs,
are pH insensitive over physiologically relevant acidities, and display a larger Stoke’s shift
(103,104). Near-IR probes based on diaminocyanines (Figure 3) have also been developed
to limit cellular damage and autofluorescence during imaging (105). Numerous other probes
bearing the o-diaminobenzene motif, including modified calcium sensors (106), luminescent
ruthenium complexes (107), and near-infrared emissive single-walled carbon nanotubes
(108), are available. Similarly, the reaction of aerobic NO with a primary amine, followed
by electrophilic aromatic substitution on the formed nitrosamine, has been used to generate a
fluorescent conjugated diazo ring scaffold with excellent selectivity for NO over other
reactive oxygen and nitrogen species (109).
2.2.2. Transition-metal-based probes for nitric oxide—An alternative approach to
NO sensing utilizes transition-metal-mediated NO reactivity and has resulted in several
probes based on Cu(II)-fluorophore scaffolds (Figure 4). In such systems, coordination of a
paramagnetic Cu(II) ion by a sensor moiety carrying a secondary amine quenches emission
of the fluorophore prior to reaction with NO. Upon reaction with NO, Cu(II) is reduced to
Cu(I) with concomitant deprotonation and nitrosation of the secondary amine, which lowers
the energy of a quenching lone pair on the nitrogen atom, thus diminishing PET quenching
in the N-nitrosated product. Such probes select for NO over other reactive oxygen and
nitrogen species, although some nonspecific but attenuated reactivity is often observed with
other radicals such as H2O2 and NO2. Unlike the o-diaminoarene sensing strategy, the
Cu(II)-mediated reactivity does not require oxygen, which makes such probes potentially
useful for imaging NO in hypoxic environments, such as those associated with
carcinogenesis.
The CuFL1 platform (Figure 4) is based on a fluorescein dye with a pendant amino-
quinoline moiety to bind Cu(II) (110–112). CuFL1 reacts directly and quickly with NO to
result in a 16-fold emission turn on; the probe maintains selectivity for NO over other
RNOS such as NO2−, NO3−, H2O2, HNO, ONOO−, O2−, and ClO−. Upon treatment with
NO, Cu(II) is reduced to Cu(I) with concomitant nitrosation of the secondary amine leading
to a fluorescence enhancement with first-order dependency on NO concentration (113). The
CuFL probe has been used to image endogenously produced nitric oxide in Raw 264.7
macrophages, SK-N-SH neuroblastoma, the gram-positive Bacillus subtilis, and Bacillus
anthracis (114,115). Modification of the FL1 platform to generate a symmetric probe (FL2)
(Figure 4) significantly increased the dynamic range (116). Introduction of ester groups on
the two upper-ring quinolines resulted in a cell-trappable version of FL2 (FL2E) (Figure 4)
that has been used to image endogenous NO in Raw 264.7 macrophages, SK-N-SH
neuroblastoma, and olfactory bulb brain slices (117).
The use of Cu(II)-mediated N-nitrosation has also been applied to detect endogenous NO
with the blue fluorophore MNIP (Figure 4) in Raw 264.7 macrophages and ASHI mouse
liver slices (118). Numerous other small-molecule transition-metal complexes, including
those of Co(II), Fe(II), Ru(II), and Rh(I), have been developed as nitric oxide sensors,
although they have not been employed in live cells (112,119–123). The strategy of binding
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NO directly to a metal center also offers an attractive platform for devising reversible probes
to detect nitric oxide, and NO release from such compounds has been amply documented
(124–126).
2.2.3. Genetically encoded probes for nitric oxide—In addition to small-molecule
transition-metal-based probes for NO, numerous constructs have been devised that use
genetic encoding of NO-reactive proteins often containing transition-metal NO-reactive
sites. An example is a fusion of two mutant green fluorescent proteins (GFPs) joined by an
MT domain, which functions as an NO indicator. The FRET response between the mutated
GFPs in response to the conformational change of MT upon reaction with NO provides a
visible readout (127). Similarly, a selective NO sensor based on a GFP-labeled heme domain
of soluble guanylyl cyclase (sGC) has been developed (128,129). Upon NO binding to sGC,
a linear and reversible response occurs owing to changes in the quantum yield of the GFP. In
another strategy, fluorescent probes for guanosine 3′,5′-cyclic monophosphate (cGMP), and
thus indirectly for NO, have been explored by attaching a cyan fluorescent protein and a
yellow fluorescent protein at the N terminus and C terminus, respectively, of cGMP
indicator proteins (130–133). FRET between the two GFPs increases with NO concentration
as the result of amplification of the cGMP concentration. In addition to the high level of NO
sensitivity, the binding of NO to sGC is reversible, reporting both increases and decreases in
biological NO.
3. INTERPLAY OF ZINC AND NITRIC OXIDE IN BIOLOGY
3.1. Nervous System
The involvement of both Zn(II) and NO in a variety of neurological dysfunctions such as
Alzheimer’s disease, as well as the neurotoxic effects of both inorganic species, has sparked
interest in studying the interplay between these two analytes in the central nervous system.
Treatment of hippocampal neurons with exogenous NO donors, including sodium
nitroprusside or the spermine-nitric oxide complex, resulted in mobilization and
accumulation of Zn(II) in brain tissue, as detected by TSQ fluorescence and Timm staining
(134). Zinc accumulation was observed in perikarya, axons, interneurons, and dentate
granule cells two hours after injection with sodium nitroprusside or spermine-nitric oxide
complex. Depending on the NO donor, differential staining of the pyramidal neurons,
interneurons, or dentate gyrus was observed. Injection of the zinc chelator N,N,N′,N′-
tetrakis(2-pyridylmethyl)ethylenediamine (TPEN) prior to NO-donor administration
abolished zinc staining.
Treatment of neurons in primary cerebrocortical cultures with high concentrations of
exogenous NO produces ONOO− and subsequent Zn(II) release from intracellular stores as
visualized by Newport Green, TSQ, and RhodZin-3 (135). Temporary punctate fluorescence
localized in the mitochondria occurred, suggesting that cytoplasmic Zn(II) may be taken up
by mitochondria. Higher Zn(II) concentrations increased O2− production, resulting in
mitochondrial dysfunction, additional ONOO− formation, and amplification of the signaling
pathway. Nitric oxide–induced zinc release could be blocked by Mn(III) tetrakis(4-benzoic
acid)porphyrin or superoxide dismutase both scavenge O2− and reduce ONOO− formation.
These results suggest that ONOO−, rather than NO alone, may be responsible for the
observed action. The overproduction of ONOO− and reactive oxygen species can activate
p38 mitogen-activated protein kinase, which in turn activates voltage-gated K+ channels,
resulting in cell volume loss and cell death. Zn(II) chelators, reactive oxygen species
scavengers, or K+ channel blockers all diminished NO-induced K+ efflux and cell death. In
similar studies, short-term exposure of cultured neurons to nonneurotoxic levels of NO
resulted in a concentration-dependent increase in intracellular free Zn(II), measured by use
Pluth et al. Page 9
Annu Rev Biochem. Author manuscript; available in PMC 2012 June 7.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
of FluoZin-3, without inducing cell death (136). These data suggest an important link
between Zn(II) and NO in apoptotic signal transduction pathways.
In a study of the role of poly(ADP-ribose) polymerase (PARP) and poly(ADP-ribose)
glycohydrolase (PARG) in zinc-mediated cell death, addition of 400 µM Zn(II) to cultured
cortical cells resulted in an increase in PARP, with reduced levels of nicotinamide adenine
dinucleotide (NAD) and ATP, resulting in cell death (137). Similarly, inhibition of the Zn-
inducible enzyme NADPH oxidase and nNOS reduced Zn(II)-induced poly(ADP-ribosyl)
ation. Upon exposure to Zn(II), NO levels in cortical cells increased as observed by DAF-
FM fluorescence, which is consistent with increased NOS activity. This study showed that
NADPH oxidase induction and nNOS contribute to PARP/PARG-mediated cell death
induced by zinc.
3.2. Cardiovascular System
In rat aortic endothelial cells stained with Zinquin-E, addition of exogenous NO results in
release of Zn(II) from MT. Increased fluorescence from Zinquin-E was observed in both the
cytoplasm and nucleus (138). Pretreatment of cells with Zn(II) prior to Zinquin-E in the
absence of an NO donor resulted in increased nuclear fluorescence, indicating that the
fluorescence observed after NO treatment is not due to NO-mediated translocation of
Zinquin to the nucleus but rather reflects Zn(II) nuclear content. Similar treatment of
Zinquin-labeled mouse lung fibroblasts with NO donors showed increased labilization of
zinc in wild type (MT+/+) but not MT-deficient (MT−/−) mutants (139). Moreover, studies in
cultured endothelial cells from lung of wild-type and MT−/− mutants revealed that MT is
vital in modulating the NO-induced change in zinc concentration in the pulmonary
endothelium. Similar investigations in cultured pulmonary aortic cells also resulted in
increased Zinquin fluorescence after treatment with NO donors. Overexpression of MT-I or
coincubation with a zinc chelator protected mitochondria from NO/Zn-mediated apoptosis
(140). Similarly, exposure of mouse lung endothelial cells to S-nitrosocysteine resulted in
increased Zn(II)-induced fluorescence from Zinquin that could be removed by addition of
the zinc chelator TPEN. No NO-mediated increase of labile Zn(II) was observed in MT-I or
MT-II knockout mice, thus indicating the requirement of MT for the NO-mediated zinc
release pathway. Pretreatment of sheep pulmonary artery endothelial cells (PAECs) with
SNAP decreased the observed lipopolysaccharide (LPS)-induced apoptosis. Chelation of
free zinc with TPEN reduced the protective effect of NO, thus suggesting that MT is the
source of the labile zinc. Similarly, exposure of PAECs to NO donors resulted in an increase
in free zinc, as observed by Zinquin fluorescence (141). Direct addition of ZnCl2 to PAECs
resulted in a dose-dependent increase in superoxide generation localized in the
mitochondria. Overexpression of the zinc-binding protein MT-I or coincubation with TPEN
protected the mitochondria from both NO- and zinc-mediated cell death.
Although NO generally has vasodilatory effects in the cardiovascular system, the NO/Zn(II)
interplay has also been implicated in hypoxia-mediated NO biosynthesis that contributes to
vasoconstriction. Under hypoxic conditions in PAECs, increased NO results in release of
Zn(II) via nitrosation of MT and induces pulmonary vasoconstriction (142). Increases in
endogenous NO were observed by the FRET construct cygnet-2 (130). MT-deficient
(MT−/−) mice displayed an 80% reduction in induced hypoxic pulmonary vasoconstriction.
These studies indicate that hypoxia can induce NO production from PAECs and that the
resultant increase in free zinc induces pulmonary vasoconstriction through a signaling
cascade.
In isolated adult rat cardiomyocytes, NO mobilizes endogenous Zn(II) by opening
mitochondrial KATP channels through the cGMP/PKG pathway. Zinc levels in such cells
were monitored with Newport Green DCF (143). Addition of SNAP increases mobile zinc
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levels, but this effect could be blocked by addition of inhibitors of sGC. PKG inhibition
blocks the effects of SNAP, whereas addition of PKG activators in the absence of SNAP
mimicked the effects of SNAP. In a similar pathway, morphine could mobilize intracellular
Zn(II) by an NO-mediated pathway in rat cardiomyocytes (51). Treatment of the
cardiomyocytes with morphine resulted in an increase in zinc as monitored by Newport
Green. This effect was attenuated with L-NG-nitroarginine methyl ester, an NO-synthase
inhibitor, suggesting that the increase in Zn(II) was mediated by NO. Similarly, treatment
with an sGC inhibitor prevented the morphine-dependent zinc release. Similar PKG
inhibition was observed and NO was detected by DAF-FM. Morphine mobilized
intracellular Zn by the NO/cGMP/PKG pathway and inhibited a mitochondrial permeability
transition pore opening by inactivation of GSK-3β.
3.3. Immune System
Both zinc and nitric oxide participate in processes orchestrated by the immune system to
defend against pathogens. Zinc deficiency leads to impaired immune function and increased
susceptibility to infection (144). Exposure to endotoxins, such as proinflammatory cytokines
and/or LPS, prompts expression of the iNOS and hence increased NO production under
inflammatory conditions (145). A correlated action of the two inorganic species is featured
within several signaling pathways in immune cells and immunologically active organs, such
as skin, heart, and lung.
In cultured murine keratinocytes during cytokine-induced inflammation, the presence of 10
µM Zn(II) decreased NO production, a result of iNOS inhibition confirmed both at the
protein and mRNA levels (146). Similarly, in ex vivo measurements on lung homogenates
from LPS-treated rats, 150-µM Zn(II) concentrations inhibited iNOS activity (147). The
influence of increased zinc concentrations on NO production is consistent with the anti-
inflammatory activity of the ion and with the adverse effects of zinc deficiency on the
immune system. Conversely, iNOS-derived NO affects intracellular zinc homeostasis in
cytokine-activated murine aortic endothelial cells (148). Following iNOS induction during
an inflammatory response, MT participates in transient release of intracellular zinc in the
nuclei, where it is observed by fluorescence microscopy as a punctate pattern after staining
with Zinquin. Although collected on different cell types, the foregoing data indicate a
potential feedback loop that links the transient concentrations of zinc and nitric oxide during
cellular response to inflammatory stimuli.
Zinc is also involved in the activation of microglia, the resident immune cells of the central
nervous system. The activation of cultured microglia is triggered by zinc through the
sequential activation of NADPH oxidase, poly(ADP-ribose)polymerase-1 and NF-κB (149).
This finding was confirmed in ex vivo measurements on mouse brain after direct injection of
ZnCl2. Nitrite measurements using the Griess assay indicated an increase in NO production
following zinc-induced microglial activation, an observation consistent with an
immunological response yet in contrast with the typical anti-inflammatory effect of zinc. In
the brain, where zinc is abundant relative to other organs and the neuronal isoform of NO
synthase is an additional source of NO, the interplay of NO and Zn in the immune response
may overlap with other phenomena involved in the neurobiology of these species, providing
an as yet unexplored contribution to neurological pathology.
SUMMARY POINTS
1. Available turn-on sensors for biologically mobile zinc offer excellent methods for
visualizing this ion with high spatial and temporal resolution. Sensors with a wide
range of affinities for mobile zinc can be selected based on the specific application.
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2. Strategies such as ratiometric imaging or specific sensor localization provide the
opportunity for sophisticated experiments involving zinc quantification or
localization with high subcellular resolution that can overcome the limitations of
optical microscopy. The development of detection systems of this nature is still in
its early stages.
3. Bright fluorescent probes for nitric oxide are available based on reactions of o-
diamines with NO under aerobic conditions. Platforms incorporating fluorescein,
rhodamine, and BODIPY dyes with a variety of absorption and emission
wavelengths as well as cellular uptake characteristics are available for different
applications.
4. Metal-based fluorescent indicators for nitric oxide based on Cu(II)-mediated N-
nitrosation of amines incorporate probes that react directly with NO. Such
constructs do not require oxygen for emission enhancement, making them ideal for
hypoxic environments.
5. Fluorescent probes for biological zinc and nitric oxide reveal multiple pathways in
which these inorganic species are interconnected in biology. Zn/NO synergism in
the neuronal, cardiovascular, and immune systems have all benefited from such
probes.
FUTURE ISSUES
1. The fields of zinc and nitric oxide sensing will profit from the development of more
sensitive and selective probes that provide in a palette of colors to facilitate study
of problems in which the concentration range of the analyte can vary.
2. Quantification of intracellular zinc is an important goal in devising new zinc
probes. This task will require a toolbox of ratiometric probes that span a wide range
of zinc affinities with large dynamic ranges.
3. Fluorescent probes able to detect nitric oxide reversibly are much desired.
Solutions to this problem may arise from the use of nitric oxide to modulate
inherently reversible interactions, such as formation of metal nitrosyls or mediation
of conformational changes.
4. A complete network map of the temporal, positional, and functional properties of
nitric oxide will require specific probes for downstream NO oxidation products and
other reactive nitrogen/oxygen species. Such probes should be highly selective and
report endogenous levels of these analytes. Differentiating NO transfer agents, such
as S-nitrosothiols, from nitric oxide will require creative chemistry.
5. Much additional work to elucidate the biological interplay between these two
important endogenous analytes can be garnered by using NO and Zn probes
concomitantly. Such experiments will require the use of probes that are compatible,
different in color, and specifically distributed in cells.
6. The utilization of site-specific probes anchored to cellular compartments will
enhance the topological resolution of fluorescence detection. Protein design and
protein labeling methodologies will continue to supply powerful strategies for site-
specific sensor design.
7. Use of other imaging techniques, such as magnetic resonance imaging, can
complement fluorescence imaging techniques. Sensors with dual fluorescence and
magnetic resonance imaging modalities will be particularly useful for monitoring
NO and Zn at different concentrations or tissue depths.
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TERMS/DEFINITIONS LIST
Förster (or
fluorescence)
resonance energy
transfer (FRET)
This occurs between the excited state of a donor molecule (D) and
the ground state of an acceptor molecule (A) through nonradiative
dipole-dipole coupling. For fluorescent chromophores, emission
from D overlaps with the absorption spectrum of A and results in
emission from A at a longer wavelength. A common application of
(F)RET is for distance measurement between two sites in
macromolecules based on the D-A energy transfer efficiency.
Photoinduced-
electron transfer
(PET)
This occurs when higher-energy lone pair electrons (often from an
amine nitrogen) quench the excited state of a fluorophore thus
extinguishing or attenuating its emission. Following photoinduced
excitation of a ground-state electron of the fluorophore, the lone pair
electrons fill the resulting vacancy and inhibit the radiative decay
process that would give rise to fluorescence emission.
Trappable
sensors
Probes that are initially cell membrane permeable but cannot recross
the cell membrane after the initial uptake. A common strategy for
modifying probes to be trapped in cells involves the incorporation of
ester groups to the probe structure. Hydrolysis of the ester moieties
by intracellular esterases releases a negatively charged membrane-
impermeable form of the probe. Sensor trappability is often critical
in tissue imaging experiments, which typically require continuous
media perfusion of the biological specimen.
ACRONYMS LIST
NOS nitric oxide synthase
RNOS reactive NO species
DPA di(2-picolyl)amine
DAF diaminofluorescein
MT metallothionein
TPEN N,N,N′,N′-tetrakis(2-pyridylmethyl)ethylenediamine
PAECs pulmonary artery epithelial cells
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Figure 1.
Selection of fluorescent turn-on sensors for biological zinc. FluoZin-3, RhodZin-3, TSQ, 6-
methoxy-8-p-toluenesulfonamidequinoline; Zinquin-A, carboxylic acid form of Zinquin;
Zinquin-E, ethyl ester form of Zinquin; ZP1, ZPP1, ZnAF-2, Newport Green DCF.
Pluth et al. Page 21
Annu Rev Biochem. Author manuscript; available in PMC 2012 June 7.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 2.
Selected ratiometric fluorescent probes for biological zinc. Et2N, nBu, NEt2, ZnIC, ZTRS, 1,
fluorescein-rhodamine construct 1.
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Figure 3.
(a) Treatment of o-phenylenediamine with NO under aerobic conditions results in triazole
formation. (b) Fluorescent probes for NO based on o-phenylenediamine functionality. DAC-
P, DAN, 2,3-diaminonaphthalene; DAF-2, DAF-2 DA, DAF-FM, DAF-FM DA, DAQ, 1,2-
diaminoanthraquinone; DAR-4, DAR-4M, DAR-4M AM, DAMBO-PH, DAMBOO, nPr.
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Figure 4.
(a) Ligands with secondary amines able to bind Cu(II) are nitrosated upon treatment of NO.
(b) Fluorescent probes for NO based on Cu(II)-mediated amine nitrosation. FL1, FL2,
FL2E, FL2A, MNIP.
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